General Information
Age Group
AdultsStatus
Active, not recruitingProtocol Number
NCT02928497
Background Information
The ASAP-TOO study is a prospective, randomized, multi-center, global investigation to establish the safety and effectiveness of the Watchman Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anti-coagulation therapy to reduce the risk of stroke. Subjects are randomized in a ratio of 2 device to 1 control to receive the Watchman LAA closure device or the control treatment of single antiplatelet medication or no medication at the discretion of the study physician.
Offered At
Inova Fairfax Hospital
3300 Gallows Rd.
Falls Church, VA 22042
Principal Investigator